Induction of immune responses in mice and pigs by oral administration of classical swine fever virus E2 protein expressed in rice calli

Archives of Virology

Volumn 159, Issue 12, 2014, Pages 3219-3230

  Jung, Myunghwan ^a   Shin, Yun Ji ^b   Kim, Ju ^b   Cha, Seung Bin ^a   Lee, Won Jung ^a   Shin, Min Kyoung ^a   Shin, Seung Won ^a   Yang, Moon Sik ^c   Jang, Yong Suk ^c   Kwon, Tae Ho ^b   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b Jeonju Bio Materials Institute   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E2, CLASSICAL SWINE FEVER VIRUS; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL; BLOOD; CD8+ T LYMPHOCYTE; CLASSICAL SWINE FEVER VIRUS; GENETICS; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOLOGY; ISOLATION AND PURIFICATION; KOREA; MOUSE; ORAL DRUG ADMINISTRATION; RICE; SECRETION (PROCESS); SWINE; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC PLANT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY-PRODUCING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL2; CLASSICAL SWINE FEVER VIRUS; INTERLEUKIN-8; KOREA; MICE; ORYZA SATIVA; PLANTS, GENETICALLY MODIFIED; SWINE; T-LYMPHOCYTE SUBSETS; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84922393831     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-014-2182-4     Document Type: Article

References (63)

1. Wengler G, Baradley DW, Collett MS, Heinz FX, Schlesinger RW, Strauss JH (1995) Family flaviviridae. In: Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, Mayo MO, Summer MD (eds) Virus taxonomy. Classification and nomenclature of viruses. Sixth Report of the International Committee on Taxonomy of Viruses. Springer, Wien New York, pp 415–427
2. Dong XN, Chen YH (2007) Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25:205–230. doi:10.1016/j.vaccine.2006.07.033
3. Risatti GR, Holinka LG, Carrillo C, Kutish GF, Lu Z, Tulman ER, Femandez Sainz I, Borca MV (2006) Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus. Virology 355:94–101. doi:10.1016/j.virol.2006.07.005
4. König M, Lengsfeld T, Pauly T, Stark R, Thiel H (1995) Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J Virol 69:6479–6486
5. Rümenapf T, Stark R, Meyers G, Thiel HJ (1991) Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 65:589–597
6. Weiland E, Stark R, Haas B, Rümenapf T, Meyers G, Thiel HJ (1990) Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol 64:3563–3569
7. Sakoda Y, Wakamoto H, Tamura T, Nomura T, Naito M, Aoki H, Morita H, Kida H, Fukusho A (2012) Development and evaluation of indirect enzyme-linked immunosorbent assay for a screening test to detect antibodies against classical swine fever virus. Jpn J Vet Res 60:85–94
8. Edwards S, Fukusho A, Lefevre PC, Lipowski A, Pejsak Z, Roehe P, Westergaard J (2000) Classical swine fever: the global situation. Vet Microbiol 73:103–119. doi:10.1016/S0378-1135(00)00138-3
9. Kim B, Song JY, Tark DS, Lim SI, Choi EJ, Kim J, Park CK, Lee BY, Wee SH, Bae YC, Kwon JH, Kang WC, Kim TY, Kim JH, Lee JH, Kang MI (2008) Feed contaminated with classical swine fever vaccine virus (LOM strain) can induce antibodies to the virus in pigs. Vet Rec 162:12–17. doi:10.1136/vr.162.1.12
10. Song J, Lim S, Jeoung H, Choi E, Hyun B, Kim B, Kim J, Shin Y, Kim J, Joo H (2013) Prevalence of classical swine fever virus in domestic pigs in South Korea: 1999–2011. Transbound Emerg Dis 60:546–551. doi:10.1111/j.1865-1682.2012.01371.x
11. Milicevic V, Dietze K, Plavsic B, Tikvicki M, Pinto J, Depner K (2013) Oral vaccination of backyard pigs against classical swine fever. Vet Microbiol 163:167–171. doi:10.1016/j.vetmic.2012.12.005
12. van Oirschot J (2003) Vaccinology of classical swine fever: from lab to field. Vet Microbiol 96:367–384. doi:10.1016/j.vetmic.2003.09.008
13. Moennig V (2000) Introduction to classical swine fever: virus, disease and control policy. Vet Microbiol 73:93–102. doi:10.1016/S0378-1135(00)00137-1
14. Sato U, Nishimura Y, Hanaki T, Nobuto K (1964) Attenuation of hog cholera virus by means of continuous cell-virus propagation (CCVP) method. Arch Gesamte Virusforsch 14:394–403
15. Graham SP, Everett HE, Johns HL, Haines FJ, Rocca SAL, Khatri M, Wright IK, Drew T, Crooke HR (2010) Characterisation of virus-specific peripheral blood cell cytokine responses following vaccination or infection with classical swine fever viruses. Vet Microbiol 142:34–40. doi:10.1016/j.vetmic.2009.09.040
16. Moormann RJ, Bouma A, Kramps JA, Terpstra C, De Smit HJ (2000) Development of a classical swine fever subunit marker vaccine and companion diagnostic test. Vet Microbiol 73:209–219. doi:10.1016/S0378-1135(00)00146-2
17. van Zijl M, Wensvoort G, De Kluyver E, Hulst M, van der Gulden H, Gielkens A, Berns A, Moormann R (1991) Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65:2761–2765
18. Feliziani F, Blome S, Petrini S, Giammarioli M, Iscaro C, Severi G, Convito L, Pietschmann J, Beer M, De Mia GM (2014) First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions. Vaccine 32:2050–2055. doi:10.1016/j.vaccine.2014.02.006
19. Streatfield SJ, Howard JA (2003) Plant-based vaccines. Int J Parasitol 33:479–493. doi:10.1016/S0020-7519(03)00052-3
20. Streatfield S (2006) Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150–157. doi:10.1016/j.ymeth.2005.09.013
21. Catmull J, Wilson ME, Kirchhoff LV, Metwali A, Donelson JE (1999) Induction of specific cell-mediated immunity in mice by oral immunization with Salmonella expressing Onchocerca volvulus glutathione S-transferase. Vaccine 17:31–39. doi:10.1016/S0264-410X(98)00147-9
22. Gomez E, Zoth SC, Carrillo E, Roux ME, Berinstein A (2008) Mucosal immunity induced by orally administered transgenic plants. Immunobiology 213:671–675. doi:10.1016/j.imbio.2008.02.002
23. Hammond J, Jansen E, Morrissy C, Williamson M, Hodgson A, Johnson M (2001) Oral and sub-cutaneous vaccination of commercial pigs with a recombinant porcine adenovirus expressing the classical swine fever virus gp55 gene. Arch Virol 146:1787–1793. doi:10.1007/s007050170064
24. Hulst MM, Westra DF, Wensvoort G, Moormann RJM (1993) Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 67:5435–5442
25. Legocki AB, Miedzinska K, Czaplińska M, Płucieniczak A, Wędrychowicz H (2005) Immunoprotective properties of transgenic plants expressing E2 glycoprotein from CSFV and cysteine protease from Fasciola hepatica. Vaccine 23:1844–1846. doi:10.1016/j.vaccine.2004.11.015
26. Marconi G, Albertini E, Barone P, Marchis FD, Lico C, Marusic C, Rutili D, Veronesi F, Porceddu A (2006) In planta production of two peptides of the classical swine fever virus (CSFV) E2 glycoprotein fused to the coat protein of potato virus X. BMC biotechnol 6:29. doi:10.1186/1472-6750-6-29
27. Sánchez O, Barrera M, Rodríguez MP, Frías MT, Figueroa NE, Naranjo P, Montesino R, Farnos O, Castell S, Venereo A (2008) Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge. Vaccine 26:988–997. doi:10.1016/j.vaccine.2007.11.014
28. Yuki Y, Tokuhara D, Nochi T, Yasuda H, Mejima M, Kurokawa S, Takahashi Y, Kataoka N, Nakanishi U, Hagiwara Y (2009) Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine 27:5982–5988. doi:10.1016/j.vaccine.2009.07.071
29. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T (2007) Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination. Proc Natl Acad Sci 104:10986–10991. doi:10.1073/pnas.0703766104
30. Sung JH, Kang ML, Lee WJ, Shin MK, Lim SI, Kim BH, Song JY, Yoo HS (2011) Improved sero-monitoring assay for classical swine fever (CSF) using the recombinant E2 protein of a recent Korean isolate. Res Vet Sci 90:329–335. doi:10.1016/j.rvsc.2010.06.003
31. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59. doi:10.1016/0378-1119(89)90358-2
32. Shin YJ, Hong SY, Kwon TH, Jang YS, Yang MS (2003) High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol Bioeng 82:778–783. doi:10.1002/bit.10635
33. Kim SH, Seo KW, Kim J, Lee KY, Jang YS (2010) The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination. J Immunol 185:5787–5795. doi:10.4049/jimmunol.0903184
34. Yasuda H, Hayashi Y, Jomori T, Takaiwa F (2006) The correlation between expression and localization of a foreign gene product in rice endosperm. Plant Cell Physiol 47:756–763. doi:10.1093/pcp/pcj049
35. Chen L, Marmey P, Taylor NJ, Brizard JP, Espinoza C, D’Cruz P, Huet H, Zhang S, de Kochko A, Beachy RN, Fauquet CM (1998) Expression and inheritance of multiple transgenes in rice plants. Nat Biotechnol 16:1060–1064
36. Shin YJ, Lee NJ, Kim J, An XH, Yang MS, Kwon TH (2010) High-level production of bioactive heterodimeric protein human interleukin-12 in rice. Enzyme Microb Technol 46:347–351. doi:10.1016/j.enzmictec.2009.12.011
37. Chu CC (1975) Establishment of an efficient medium for another culture of rice through comparative experiments on the nitrogen sources. Sci Sin 18:659–668
38. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995
39. Chuang CF, Meyerowitz EM (2000) Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana. Proc Natl Acad Sci USA 97:4985–4990. doi:10.1073/pnas.060034297
40. Cha SB, Rayamajhi N, Kang ML, Lee WJ, Shin MK, Yoo HS (2010) Comparative study of gamma interferon production in mice immunized with outer membrane proteins and whole bacteria of Brucella abortus. Jpn J Infect Dis 10:49–51
41. MacDonald T, Carter P (1982) Isolation and functional characteristics of adherent phagocytic cells from mouse Peyer’s patches. Immunology 45:769–774
42. Piriou L, Chevallier S, Hutet E, Charley B, Le Potiera MF, Albina E (2003) Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet Res 34:389–404. doi:10.1051/vetres:2003013
43. Liu S, Tu C, Wang C, Yu X, Wu J, Guo S, Shao M, Gong Q, Zhu Q, Kong X (2006) The protective immune response induced by B cell epitope of classical swine fever virus glycoprotein E2. J Virol Methods 134:125–129. doi:10.1016/j.jviromet.2005.12.008
44. Reimann I, Depner K, Trapp S, Beer M (2004) An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322:143–157. doi:10.1016/j.virol.2004.01.028
45. Devriendt B, De Geest BG, Cox E (2011) Designing oral vaccines targeting intestinal dendritic cells. Expert Opin Drug Deliv 8:467–483. doi:10.1517/17425247.2011.561312
46. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR (1994) Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 6:572–583. doi:10.1016/0952-7915(94)90144-9
47. Zeng F, Chow KYC, Hon CC, Law KM, Yip CW, Chan KH, Peiris JSM, Leung FCC (2004) Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochem Biophys Res Commun 315:1134–1139. doi:10.1016/j.bbrc.2004.01.166
48. Tizard IR (2004) Veterinary immunology: an introduction, 7th edn. Patricia Tannian, Philadelphia
49. Brayden DJ, Jepson MA, Baird AW (2005) Keynote review: intestinal Peyer’s patch M cells and oral vaccine targeting. Drug Discov Today 10:1145–1157. doi:10.1016/S1359-6446(05)03536-1
50. Riordan SM, Skinner N, Nagree A, McCallum H, McIver CJ, Kurtovic J, Hamilton JA, Bengmark S, Williams R, Visvanathan K (2003) Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37:1154–1164. doi:10.1053/jhep.2003.50180
51. Pauly T, Elbers K, König M, Lengsfeld T, Saalmüller A, Thiel HJ (1995) Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J Gen Virol 76:3039–3049
52. Kourilsky P, Truffa-Bachi P (2001) Cytokine fields and the polarization of the immune response. Trends Immunol 22:502–509. doi:10.1016/S1471-4906(01)02012-9
53. Toledo JR, Barrera M, Farnós O, Gómez S, Rodríguez MP, Aguero F, Ormazabal V, Parra NC, Suárez L, Sánchez O (2010) Human αIFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs. Vaccine 28:7907–7914. doi:10.1016/j.vaccine.2010.09.073
54. Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ (2009) Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice. Vet Immunol Immunopathol 131:158–166. doi:10.1016/j.vetimm.2009.04.003
55. Schirmbeck R, Reimann J (2001) Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Intervirology 44:115–123. doi:10.1159/000050038
56. Wienhold D, Armengol E, Marquardt A, Marquardt C, Voigt H, Büttner M, Saalmüller A, Pfaff E (2005) Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination. Vet Res 36:571–587. doi:10.1051/vetres:2005019
57. Lummus ZL, Alam R, Bernstein JA, Bernstein DI (1998) Diisocyanate antigen–enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-α by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 102:265–274. doi:10.1016/S0091-6749(98)70095-8
58. Bensaude E, Turner JL, Wakeley PR, Sweetman DA, Pardieu C, Drew TW, Wileman T, Powell PP (2004) Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J Gen Virol 85:1029–1037. doi:10.1099/vir.0.19637-0
59. Renson P, Le Dimna M, Gabriel C, Levai R, Blome S, Kulcsar G, Koenen F, Le Potier M (2014) Cytokine and Immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of Classical swine fever virus. Res Vet Sci 96:389–395. doi:10.1016/j.rvsc.2014.01.002
60. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29:313–326. doi:10.1089/jir.2008.0027
61. Rynda A, Maddaloni M, Mierzejewska D, Ochoa-Repáraz J, Maślanka T, Crist K, Riccardi C, Barszczewska B, Fujihashi K, McGhee JR, Pascual DW (2008) Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein σ1. J Immunol 180:5187–5200. doi:10.4049/jimmunol.180.8.5187
62. Weiner HL, da Cunha AP, Quintana F, Wu H (2011) Oral tolerance. Immunol Rev 241:241–259. doi:10.1111/j.1600-065X.2011.01017.x
63. Ogra PL, Faden H, Welliver RC (2001) Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14:430–445. doi:10.1128/CMR.14.2.430-445.2001